Company / Net Debt per Share
Aclaris Therapeutics, Inc. Net Debt per Share History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.28
FY2020
5-year range
-
FY2018-FY2020
Trend
-
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.28 in FY2020.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -$0.28 | - |
| FY2019 | - | - |
| FY2018 | -$4.47 | - |
| FY2017 | - | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026